Delivery Order SPE2DR25D3201-SPE2DR26FT7UX
Award Date 3/12/26
Potential Completion Date 4/2/26
Potential Value $1.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $49,473 delivery order to AmerisourceBergen Drug Corp on February 24, 2026, for HYPERRAB 300 unit/mL vial 5 mL pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 17, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $1,649.10 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for HYPERRAB 300 Unit/ML Vial 5ML, with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, with a ceiling value of $6,316.80 for HYPERRAB 300 unit/mL vial pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 16, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $1,895.04 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for HYPERRAB 300 Unit/ML vial under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), with an ultimate completion date of April 2, 2026.</p> <p>Place of performance is Conshohocken, PA 19428. The order is priced firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,245.50 for HYPERRAB 300 unit/mL vial 5mL. This is a firm fixed-price delivery order under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $8,245.50 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for HYPERRAB 300 unit/ml vial 5ml pharmaceutical supply. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price...
- The Defense Logistics Agency issued a $29,683.80 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for HYPERRAB 300 unit/mL vial 5 mL, with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999.00 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for $3,158.40 (firm fixed price) under the DLA Troop Support Medical indefinite delivery contract for HYPERRAB 300 unit/ml vial pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a $1,790.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vial (5ML) on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside contract, competitively awarded to support federal medical procurement needs. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities, with a ceiling value of $8,668.70 and a completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT7UXDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for HYPERRAB 300 Unit/ML vial medication with a ceiling value of $1,895.04. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of April 2, 2026. No set-aside was used.
Generated 6/10/26, 11:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/11/26 |